Kavya Ramkumar
Impact in
- Oncology top 5%
- Lung Cancer Research Studies
- Cancer Immunotherapy and Biomarkers
- PARP inhibition in cancer therapy
- Infectious Diseases top 10%
- HIV/AIDS drug development and treatment
Papers in
- Oncology 22
- Lung Cancer Research Studies 13
- Cancer Immunotherapy and Biomarkers 6
- PARP inhibition in cancer therapy 2
-
- HIV/AIDS drug development and treatment 4
- COVID-19 Clinical Research Studies 3
- SARS-CoV-2 and COVID-19 Research 3
- Co-authors
- Nouri Neamati (7 shared papers)Srinivas Odde (3 shared papers)Erik Serrao (2 shared papers)Lauren A. Byers (11 shared papers)Carl Michael Gay (10 shared papers)Catherine Allison Stewart (11 shared papers)Li Shen (7 shared papers)Jing Wang (7 shared papers)
- Journals
- Journal of Thoracic Oncology (9 papers)Annals of Oncology (3 papers)Clinical Cancer Research (2 papers)Molecular Cancer (2 papers)Cancer Cell (2 papers)
- Partner nations
- United StatesItalyRussia
In The Last Decade
Kavya Ramkumar
29 papers receiving 1.7k citations
Kavya Ramkumar's Hit Papers
Peers
Comparison fields: 5 of 72
- Oncology 900
- Infectious Diseases 146
- Cancer Research 93
- Immunology 103
- Pulmonary and Respiratory Medicine 147
Countries citing papers authored by Kavya Ramkumar
This map shows the geographic impact of Kavya Ramkumar's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kavya Ramkumar with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kavya Ramkumar more than expected).
Fields of papers citing papers by Kavya Ramkumar
This network shows the impact of papers produced by Kavya Ramkumar. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kavya Ramkumar. The network helps show where Kavya Ramkumar may publish in the future.
Co-authors
The 25 scholars most cited alongside Kavya Ramkumar, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 32 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Patterns of transcription factor programs and immune pathway activation define four major subtypes of SCLC with distinct therapeutic vulnerabilities Hit paper breakdown → | 2021 | 722 |
| 2 | 2009 | 132 | |
| 3 | 2020 | 124 | |
| 4 | 2019 | 102 | |
| 5 | 2021 | 89 | |
| 6 | 2016 | 61 | |
| 7 | 2021 | 50 | |
| 8 | 2021 | 46 | |
| 9 | 2021 | 45 | |
| 10 | 2010 | 44 | |
| 11 | 2020 | 44 | |
| 12 | 2008 | 37 | |
| 13 | 2021 | 36 | |
| 14 | 2010 | 31 | |
| 15 | 2023 | 26 | |
| 16 | 2022 | 15 | |
| 17 | 2024 | 14 | |
| 18 | 2022 | 13 | |
| 19 | 2020 | 11 | |
| 20 | 2025 | 11 |
About Kavya Ramkumar
Kavya Ramkumar is a scholar working on Oncology, Infectious Diseases, Pulmonary and Respiratory Medicine, Molecular Biology and Cancer Research, having authored 32 papers that have together received 1.7k indexed citations. Recurring topics across this work include Lung Cancer Research Studies (13 papers), Cancer Immunotherapy and Biomarkers (6 papers), Lung Cancer Treatments and Mutations (4 papers), HIV/AIDS drug development and treatment (4 papers), COVID-19 Clinical Research Studies (3 papers), DNA Repair Mechanisms (3 papers), SARS-CoV-2 and COVID-19 Research (3 papers) and PARP inhibition in cancer therapy (2 papers). The work is most often cited by research in Oncology (900 citations), Infectious Diseases (146 citations), Cancer Research (93 citations), Immunology (103 citations) and Pulmonary and Respiratory Medicine (147 citations). Kavya Ramkumar has collaborated with scholars based in United States, Italy and Russia. Frequent co-authors include Nouri Neamati, Srinivas Odde, Erik Serrao, Lauren A. Byers, Carl Michael Gay, Catherine Allison Stewart, Li Shen, Jing Wang, Robert J. Cardnell and Mats E. Ljungman. Their work appears in journals such as Journal of Thoracic Oncology, Annals of Oncology, Clinical Cancer Research, Molecular Cancer and Cancer Cell.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.